Preventing rejection in neonatal transplantation involves a combination of careful donor-recipient matching, immunosuppressive medications, and close monitoring. Key strategies include:
HLA Matching: Ensuring compatibility between the donor and recipient's human leukocyte antigens (HLA) to reduce the likelihood of rejection. Immunosuppressive Medications: Using drugs to suppress the immune response and prevent the body from attacking the transplanted organ. Monitoring and Follow-up: Regular monitoring to detect early signs of rejection and adjusting treatment protocols as needed.
